The real-world data showed lower rates of atrial fibrillation and hypertension associated with the second-generation Bruton ...

Novel therapies for multiple myeloma (MM), including chimeric antigen receptor T-cell and bispecific antibodies, extend lives but raise concerns about treatment costs and adherence, and they haven't ...

Employers discover innovative strategies for enhancing employee engagement and access to care at the Greater Philadelphia Business Coalition on Health (GPBCH) Annual Conference, fostering actionable ...

The FDA approved retifanlimab (Zynyz; Incyte) as the first and only first-line treatment for advanced anal cancer, supported ...

While the US leads in early-phase obesity trials and investment, the country also faces challenges in disease burden, trial ...

A systematic review and subsequent expert review gave comprehensive insight into prognostic factors for patients receiving ...

The meta-analysis of 9 studies showed high sensitivity with slightly lower specificity with the less-invasive option for ...

A new analysis looked at estimated out-of-pocket costs for etanercept, ustekinumab, and ibrutinib, specialty drugs that often ...

The new executive order contains multiple provisions if pharmaceutical companies do not offer "most-favored nation" pricing ...

Despite advances in diabetes care, new research reveals persistent economic disadvantages for middle-aged adults living with ...

Study findings show ChatGPT-4o provides accurate, complete, and trustworthy responses to patient-generated colorectal cancer ...

Facility-level disparities in adopting minimally invasive interval debulking surgery for ovarian cancer highlight urgent ...